Literature DB >> 18618483

A transformation procedure for recalcitrant tomato by addressing transgenic plant-recovery limiting factors.

Alejandro D Fuentes1, Pedro L Ramos, Yadira Sánchez, Danay Callard, Aleines Ferreira, Kenia Tiel, Karen Cobas, Raisa Rodríguez, Carlos Borroto, Vivian Doreste, Merardo Pujol.   

Abstract

Agrobacterium tumefaciens technology is the battle horse for tomato genetic transformation. However, tomato varieties with low regeneration capacity are very difficult to transform. In the past, tomato transformation through Agrobacterium infection was focused on varieties capable of high regeneration yield, while successful transformation of low regenerable cultivars has not been reported. The genotype response to tissue culture conditions is believed to drive the frequency of regeneration of transgenic plant, whereas the capacity for cell proliferation could determine the transformation efficiency through this technology. The Campbell-28 cultivar is an example of constraints arising from a high morphogenetic potential with low conversion compared to normal plants. In the present work the roles that contribute to improved transgenic plant recovery from this recalcitrant variety were explored for factors like Agrobacterium concentration and antibiotics for bacterial removal and transformant selection. Analysis of the efficiency from independent transformation experiments revealed a more than twofold increase of transformant regeneration after selection on ammonium glufosinate compared to kanamycin selection, showing a transformation efficiency of 21.5%.

Entities:  

Mesh:

Year:  2008        PMID: 18618483     DOI: 10.1002/biot.200700187

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  1 in total

1.  Comparison of efficiency and time to regeneration of Agrobacterium-mediated transformation methods in Medicago truncatula.

Authors:  Li Wen; Yuanling Chen; Elise Schnabel; Ashley Crook; Julia Frugoli
Journal:  Plant Methods       Date:  2019-02-28       Impact factor: 4.993

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.